04 Sep 2023

DBM Hebelstr. 20, 2nd floor seminar room

Prof. Gennaro De Libero

CANCELLED: Immunomeeting - Guest Presenter

Unfortunately the Immunomeeting presentation scheduled for Monday 4th September has had to be cancelled. This presentation will be rescheduled for a later date. Daniela Latorre, SNSF PRIMA Group Leader, Human Neuroimmunology Lab, ETH Zurich, Institute of Microbiology will present "Dissecting autoreactive T cell immunity in human neurological disorders". Carolyn King will host Daniela Latorre.

Dr. Daniela Latorre is an immunologist at the Institute of Microbiology, ETH Zurich. During her career, she gained competence on human immunology ranging from innate to adaptive immune responses. After obtaining her PhD in Immunology at “Sapienza” University of Rome, Italy in 2013, she moved to Switzerland to perform her Postdoctoral training in the laboratory of Prof. Federica Sallusto first at the Institute for Research in Biomedicine (IRB) in Bellinzona and later at the newly established Medical Immunology laboratory at ETHZ. During these years, she focused her studies on several aspects of human T cells biology in physiological and pathological conditions, including autoimmunity and immunodeficiency. Her main postdoctoral work provided the first solid evidence of the autoimmune basis of narcolepsy, a rare neurological disorder (Latorre D et al., Nature, 2018) and opened new perspectives in the field of sleep-related disorders by prompting new studies with major translational implications to the clinics (SPHYNCS study). This research earned her several prizes, including the well-renowned Pfizer Research Prize 2020, the Young Scientist Award 2019 by EU-NN and the Best International Young Researcher on Narcolepsy 2018 by AIN. Since 2019, she has received 10 research grants (total amount 2.7 Million CHF), including the highly competitive PRIMA Grant from the Swiss National Science Foundation (15% success rate), which allowed her to start an independent career path and set up theHuman Neuroimmunology Groupat the ETH Zurich in January 2020, where she has independent group leader position. Her research employs state-of-the-art technologies to study human self-reactive T cells in immune-mediated neurological diseases, including Guillain Barré Syndrome and Multiple Sclerosis, with the overarching goal to gain knowledge of basic aspects of human T cell biology in health and autoimmunity and then translate those findings into biomedical applications.Her profile has garnered recognition not only as a scientist but also as a mentor for young generation of researchers through the establishment of the Swiss young Immunology society (SYIS) as well as invited contributions to several spotlight articles, such as an ETH interview, “Women in STEM Viewpoint” by the Journal of Experimental Medicine, and "Rising Stars" piece by the European Journal of Immunology.

Export event as iCal